Merck Requesting FDA Emergency Use Authorization for Covid Anti-Viral Pill

window.amJwVideos = window.amJwVideos || []; window.amJwVideos.push(‘jw-hook-Bhrs4fUV’); window.amJwAdthriveVideos = window.amJwAdthriveVideos || []; window.amJwAdthriveVideos.push(‘jw-adthrive-hook-Bhrs4fUV’);

The pharmaceutical company Merck and their partners at Ridgeback Biotherapeutics are seeking FDA emergency use authorization for an experimental pill they developed to treat non-severe coronavirus cases.

Merck announced that they are requesting the authorization for molnupiravir after a series of trials suggested that the drug reduced the risk of hospitalization and death for Covid patients by around 50 percent. The drug can be consumed in capsule form, and if the FDA grants the pill their approval, it will be the first oral medicine against Covid.

The latest
Read more…

Please follow and like us: